The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Molecular Cloning and Characterization of a Novel Histone Deacetylase HDAC10
Open accessAbstract
The growing number of proteins controlled by reversible acetylation suggests the existence of a large number of acetyltransferases and deacetylases. Here, we report the identification of a novel class II histone deacetylase, HDAC10. Homology comparison indicates that HDAC10 is most similar to HDAC6. Both contain a unique, putative second catalytic domain not found in other HDACs. In HDAC10, however, this domain is not functional. This tandem organization of two catalytic domains confers resistance to the inhibitors trapoxin B and sodium butyrate, which potently inhibit the deacetylase activity of all other HDAC members. Thus, HDAC10 and HDAC6 share unusual structural and pharmacological characteristics. However, unlike HDAC6, which is normally a cytoplasmic deacetylase, HDAC10 resides in both the nucleus and cytoplasm. In the nucleus, when tethered to a promoter, HDAC10 represses transcription independent of its deacetylase activity, indicating that HDAC10 contains a distinct transcriptional repressor domain. These observations suggest that HDAC10 might uniquely play roles both in the nucleus, as a transcriptional modulator, and in the cytoplasm in an unidentified role. Together, our results identify HDAC10 as a novel deacetylase with distinct structure, pharmacology and localization and further expand the complexity of the HDAC family.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HDAC10 is highly expressed in the liver, spleen and kidney1819, enriched in the cytoplasm19 and resistant to inhibition by sodium butyrate20.”
From Histone deacetylase 10 structure and molecular function as a polyamine deacetylase (2017) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Mammalian Histone Deacetylase Related to the Yeast Transcriptional Regulator Rpd3p
Taunton, J., Hassig, C. A., & Schreiber, S. L. (1996) · Science · doi:10.1126/science.272.5260.408 · Cited by 1,829
Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
Finnin, M. S., Donigian, J. R., Cohen, A., Richon, V. M., Rifkind, R. A., Marks, P. A., Breslow, R., & Pavletich, N. P. (1999) · Nature · doi:10.1038/43710 · Cited by 1,714
Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation
McKinsey, T. A., Zhang, C., Lu, J., & Olson, E. N. (2000) · Nature · doi:10.1038/35040593 · Cited by 1,051
A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases
Richon, V. M., Emiliani, S., Verdin, E., Webb, Y., Breslow, R., Rifkind, R. A., & Marks, P. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3003 · Cited by 914
Microtubules containing acetylated alpha-tubulin in mammalian cells in culture.
Piperno, G., LeDizet, M., & Chang, X. J. (1987) · The Journal of cell biology · doi:10.1083/jcb.104.2.289 · Cited by 873
Three proteins define a class of human histone deacetylases related to yeast Hda1p
Grozinger, C. M., Hassig, C. A., & Schreiber, S. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.4868 · Cited by 770
Drosophila ultraspiracle modulates ecdysone receptor function via heterodimer formation
Yao, T., Segraves, W. A., Oro, A. E., McKeown, M., & Evans, R. M. (1992) · Cell · doi:10.1016/0092-8674(92)90266-f · Cited by 720
Self-citationYoshida, M., Horinouchi, S., & Beppu, T. (1995) · BioEssays · doi:10.1002/bies.950170510 · Cited by 715
Saito, A., Yamashita, T., Mariko, Y., Nosaka, Y., Tsuchiya, K., Ando, T., Suzuki, T., Tsuruo, T., & Nakanishi, O. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.8.4592 · Cited by 696
Regulation of activity of the transcription factor GATA-1 by acetylation
Boyes, J., Byfield, P., Nakatani, Y., & Ogryzko, V. (1998) · Nature · doi:10.1038/25166 · Cited by 694
Flagged first, then by citations
Research works printed but not linked: 2
- Allfrey, 1964, Proc. Natl, Acad. Sci. U. S. A., 61, 768
- Cohen, 1999, Anticancer Res., 19, 4999
Cited by
Sorted by citations
Items 101–200 of 262
Peng, X., Li, L., Chen, J., Ren, Y., Liu, J., Yu, Z., Cao, H., & Chen, J. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01863 · Cited by 69
HDAC10 promotes lung cancer proliferation via AKT phosphorylation
Yang, Y., Huang, Y., Wang, Z., Wang, H.-T., Duan, B., Ye, D., Wang, C., Jing, R., Leng, Y., Xi, J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10673 · Cited by 67
Alinsug, M. V., Chen, F. F., Luo, M., Tai, R., Jiang, L., & Wu, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030846 · Cited by 71
HDAC6 controls the kinetics of platelet activation
Sadoul, K., Wang, J., Diagouraga, B., Vitte, A.-L., Buchou, T., Rossini, T., Polack, B., Xi, X., Matthias, P., & Khochbin, S. (2012) · Blood · doi:10.1182/blood-2012-05-428011 · Cited by 67
New perspectives of valproic acid in clinical practice
Činčárová, L., Zdráhal, Z., & Fajkus, J. (2013) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2013.853037 · Cited by 64
Class IIa histone deacetylases: conducting development and differentiation
Martin, M., Kettmann, R., & Dequiedt, F. (2009) · The International Journal of Developmental Biology · doi:10.1387/ijdb.082698mm · Cited by 63
Chromatin remodeling and stem cell theory of relativity
Černý, J., & Quesenberry, P. J. (2004) · Journal of Cellular Physiology · doi:10.1002/jcp.20071 · Cited by 61
HDAC Inhibition in Lupus Models
Reilly, C. M., Regna, N. L., & Mishra, N. (2011) · Molecular Medicine · doi:10.2119/molmed.2011.00055 · Cited by 60
Radhakrishnan, R., Li, Y., Xiang, S., Yuan, F., Yuan, Z., Telles, E., Fang, J., Coppola, D., Shibata, D., Lane, W. S., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.612945 · Cited by 59
Histone deacetylases and atherosclerosis
Zheng, X., Zhou, T., Wang, X., Tong, X.-H., & Ding, J. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.12.048 · Cited by 56
Dhakal, B. K., & Mulvey, M. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805010200 · Cited by 56
Classical HDACs in the regulation of neuroinflammation
Dai, Y., Wei, T.-F., Shen, Z., Bei, Y., Lin, H., & Dai, H. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105182 · Cited by 55
The therapeutic uses of chromatin-modifying agents
Mai, A. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.6.835 · Cited by 55
Lai, I., Lin, T.-P., Yao, Y., Lin, C., Hsieh, M.-J., & Yang, W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.061861 · Cited by 54
SHP Represses Transcriptional Activity via Recruitment of Histone Deacetylases
Gobinet, J., Carascossa, S., Cavaillès, V., Vignon, F., Nicolas, J., & Jalaguier, S. (2005) · Biochemistry · doi:10.1021/bi047308d · Cited by 51
Histone deacetylase 10, a potential epigenetic target for therapy
Cheng, F., Zheng, B., Wang, J., Zhao, G., Yao, Z., Niu, Z., & He, W. (2021) · Bioscience Reports · doi:10.1042/bsr20210462 · Cited by 50
Islam, R., Dash, D., & Singh, R. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155720 · Cited by 51
Steimbach, R. R., Herbst‐Gervasoni, C. J., Lechner, S., Stewart, T. M., Klinke, G., Ridinger, J., Géraldy, M. N. E., Tihanyi, G., Foley, J. R., Uhrig, U., et al. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c05030 · Cited by 51
Xu, X., Xie, C., Edwards, H. J., Zhou, H., Buck, S. A., & Ge, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017138 · Cited by 50
Gonzales, E. R., Chen, H., Munuve, R. M., Mehrani, T., Britten-Webb, J., Nadel, A., Alam, H. B., Wherry, D. C., Burris, D., & Koustova, E. (2006) · Shock · doi:10.1097/01.shk.0000209522.28120.c8 · Cited by 50
Lombardi, P. M., Angell, H. D., Whittington, D. A., Flynn, E. F., Rajashankar, K. R., & Christianson, D. W. (2011) · Biochemistry · doi:10.1021/bi101859k · Cited by 50
HDAC-class II specific inhibition involves HDAC proteasome-dependent degradation mediated by RANBP2
Scognamiglio, A., Nebbioso, A., Manzo, F., Valente, S., Mai, A., & Altucci, L. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.07.007 · Cited by 51
Zhao, W., Han, H.-B., & Zhang, Z. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.06.009 · Cited by 49
Odd-chain fatty acids as novel histone deacetylase 6 (HDAC6) inhibitors
Ediriweera, M. K., To, N. B., Lim, Y., & Cho, S. K. (2021) · Biochimie · doi:10.1016/j.biochi.2021.04.011 · Cited by 49
Meng, Q., Chen, X., Sun, L., Zhao, C., Sui, G., & Cai, L. (2010) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-010-0651-y · Cited by 48
Xu, Y., Sengupta, P. K., Seto, E., & Smith, B. D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511724200 · Cited by 48
Wang, G., He, J., Zhao, J., Yun, W., Xie, C., Taub, J. W., Azmi, A. S., Mohammad, R. M., Dong, Y., Kong, W., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052095 · Cited by 47
Santander, V. S., Bisig, C. G., Purro, S. A., Casale, C. H., Arce, C. A., & Barra, H. S. (2006) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-006-9212-9 · Cited by 46
Su, M., Gong, X.-Y., & Liu, F. (2021) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1877656 · Cited by 46
Class IIA HDACs in the regulation of neurodegeneration
Majdzadeh, N. (2007) · Frontiers in bioscience · doi:10.2741/2745 · Cited by 44
HDACi: molecular mechanisms and therapeutic implications in the innate immune system
Suliman, B. A., Xu, D., & Williams, B. R. G. (2011) · Immunology and Cell Biology · doi:10.1038/icb.2011.92 · Cited by 44
Lysine acetylation of cytoskeletal proteins: Emergence of an actin code
Mu, A., Latario, C. J., Pickrell, L. E., & Higgs, H. N. (2020) · The Journal of Cell Biology · doi:10.1083/jcb.202006151 · Cited by 45
Histone deacetylases 1 and 2 are required for brain development
Jaworska, J., Ziemka‐Nałęcz, M., & Zalewska, T. (2015) · The International Journal of Developmental Biology · doi:10.1387/ijdb.150071tz · Cited by 43
Ragno, R., Simeoni, S., Rotili, D., Caroli, A., Botta, G., Brosch, G., Massa, S., & Mai, A. (2007) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2007.05.004 · Cited by 41
Pramanik, S. D., Halder, A. K., Mukherjee, U., Kumar, D., Dey, Y. N., & Mogana, R. (2022) · Frontiers in Chemistry · doi:10.3389/fchem.2022.948217 · Cited by 41
Histone Deacetylase Cytoplasmic Trapping by a Novel Fluorescent HDAC Inhibitor
Kong, Y., Jung, M., Wang, K., Grindrod, S. C., Velena, A., Lee, S. A., Dakshanamurthy, S., Yang, Y., Miessau, M., Zheng, C., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0779 · Cited by 44
Epigenetics and Testicular Cancer: Bridging the Gap Between Fundamental Biology and Patient Care
Nicu, A.-T., Medar, C., Chifiriuc, M. C., Pîrcălăbioru, G. G., & Burlibaşa, L. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.861995 · Cited by 40
Class II and IV HDACs function as inhibitors of osteoclast differentiation
Blixt, N. C., Faulkner, B., Astleford, K., Lelich, R., Schering, J., Spencer, E., Gopalakrishnan, R., Jensen, E. D., & Mansky, K. C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185441 · Cited by 41
You, D., Richardson, J. R., & Aleksunes, L. M. (2020) · Drug Metabolism and Disposition · doi:10.1124/dmd.119.089953 · Cited by 40
Liao, W., Sun, J., Liu, W., Li, W., Jia, J., Ou, F., Su, K., Zheng, Y.-H., Zhang, Z., & Sun, Y.-P. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27873 · Cited by 37
Epigenetics: tools and technologies
Janzen, W. P., Wigle, T. J., Jin, J. J., & Frye, S. V. (2010) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2010.07.004 · Cited by 38
Gao, C., Cheng, X., Lam, M. C., Liu, Y., Liu, Q., Chang, K.-S., & Kao, H. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-11-1203 · Cited by 36
Arce, C. A., Casale, C. H., & Barra, H. S. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06615.x · Cited by 35
Gene silencing by the thyroid hormone receptor
Eckey, M., Moehren, U., & Baniahmad, A. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.10.026 · Cited by 35
Epigenetic assays for chemical biology and drug discovery
Gul, S. (2017) · Clinical Epigenetics · doi:10.1186/s13148-017-0342-6 · Cited by 31
The role of histone deacetylases in cardiac energy metabolism in heart diseases
Yu, Q., Zhao, G., Liu, J., Peng, Y., Xu, X., Zhao, F., Shi, Y., Jin, C., Zhang, J., & Wei, B. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155532 · Cited by 33
Inhibitors selective for HDAC6 in enzymes and cells
Gupta, P. K., Reid, R. C., Liu, L., Lucke, A. J., Broomfield, S., Andrews, M. R., Sweet, M. J., & Fairlie, D. P. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.09.100 · Cited by 31
HDAC expression and activity is upregulated in diseased lupus-prone mice
Regna, N. L., Vieson, M. D., Gojmerac, A. M., Luo, X., Caudell, D. L., & Reilly, C. M. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.10.006 · Cited by 30
Omonijo, O., Wongprayoon, P., Ladenheim, B., McCoy, M. T., Govitrapong, P., Jayanthi, S., & Cadet, J. L. (2014) · NeuroToxicology · doi:10.1016/j.neuro.2014.10.008 · Cited by 30
An Overview of Naturally Occurring Histone Deacetylase Inhibitors
Kim, B., & Hong, J. (2014) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666141208105614 · Cited by 30
Im, H., Grass, J. A., Christensen, H. M., Perkins, A. C., & Bresnick, E. H. (2002) · Biochemistry · doi:10.1021/bi026786q · Cited by 30
An Overview of HDAC Inhibitors and their Synthetic Routes
Peng, X., Liao, G., Sun, P., Yu, Z., & Chen, J. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666190227221507 · Cited by 28
Histone Deacetylases and Cardiometabolic Diseases
Yiew, K. H., Chatterjee, T. K., Hui, D. Y., & Weintraub, N. L. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.305046 · Cited by 28
Krishna, N. H., Anchi, P., Manasa, K. L., Soni, J. P., Godugu, C., Shankaraiah, N., & Kamal, Ä. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.105461 · Cited by 29
Qi, J., Li, J., Bie, B., Shi, M., Zhu, M., Tian, J., Zhu, K., Sun, J., Mu, Y., Li, Z., et al. (2022) · Phytotherapy Research · doi:10.1002/ptr.7613 · Cited by 28
Ru, J., Wang, Y., Li, Z., Wang, J., Ren, C., & Zhang, J. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115800 · Cited by 28
Terracciano, S., Micco, S. D., Bifulco, G., Gallinari, P., Riccio, R., & Bruno, I. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.03.022 · Cited by 27
Ahmad, M., Hamid, A., Hussain, A., Majeed, R., Qurishi, Y., Bhat, J. A., Najar, R. A., Qazi, A. K., Zargar, M. A., Singh, S. K., et al. (2012) · DNA and Cell Biology · doi:10.1089/dna.2011.1575 · Cited by 27
Ganai, S. A., Shanmugam, K., & Mahadevan, V. (2014) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2013.879073 · Cited by 27
Evolutionary relationships among protein lysine deacetylases of parasites causing neglected diseases
Scholte, L., Mourão, M. D. M., Pais, F. S.-M., Melesina, J., Robaa, D., Volpini, Â. C., Sippl, W., Pierce, R. J., Oliveira, G., & Nahum, L. A. (2017) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2017.05.011 · Cited by 27
Yuan, S., Tan, R., Sun, M., Yuan, L., Ruiz, M., Dupuis, J., Hu, Q., & Zhu, L. (2022) · Hypertension · doi:10.1161/hypertensionaha.122.19560 · Cited by 24
Komorowsky, C. V., Ocker, M., & Goppelt‐Struebe, M. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00674.x · Cited by 24
The Impact of Protein Acetylation/Deacetylation on Systemic Lupus Erythematosus
Ren, J., Panther, E. J., Liao, X., Grammer, A. C., Lipsky, P. E., & Reilly, C. M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19124007 · Cited by 25
Histone deacetylase‑2: A potential regulator and therapeutic target in liver disease (Review)
Liu, Y.-R., Wang, J., Huang, Z., Chen, R.-N., Cao, X., Zhu, D., Yu, H., Wang, X., Zhou, H.-Y., Xia, Q., et al. (2021) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2021.4964 · Cited by 23
Histone Acetylation and Deacetylation
Fass, D. M., Kemp, M. M., Schroeder, F. A., Wagner, F. F., Wang, Q., & Holson, E. B. (2012) · Wiley-VCH eBooks · doi:10.1002/3527600906.mcb.201100036 · Cited by 23
Obayashi, H., Nagano, Y., Takahashi, T., Seki, T., Tanaka, S., Sakai, N., Matsumoto, M., & Maruyama, H. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.12.048 · Cited by 20
Islam, R., Dash, D., & Singh, R. (2023) · Scientific Reports · doi:10.1038/s41598-023-36678-0 · Cited by 24
Zinc Dependent Histone Deacetylase Inhibitors in Cancer Therapeutics: Recent Update
Sultana, F., Manasa, K. L., Shaik, S. P., Bonam, S. R., & Kamal, Ä. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180530094120 · Cited by 21
Mai, A., Massa, S., Valente, S., Simeoni, S., Ragno, R., Bottoni, P., Scatena, R., & Brosch, G. (2005) · ChemMedChem · doi:10.1002/cmdc.200500015 · Cited by 21
Sadia, K., Castagna, A., Udali, S., Ambrosani, F., Pattini, P., Beri, R., Argentino, G., Masutti, M., Moruzzi, S., & Friso, S. (2025) · Cells · doi:10.3390/cells14171337 · Cited by 22
Restoration of mutant hERG stability by inhibition of HDAC6
Li, P., Kurata, Y., Mahati, E., Ninomiya, H., Higaki, K., Taufiq, F., Morikawa, K., Shirayoshi, Y., Horie, M., & Hisatome, I. (2018) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2018.01.009 · Cited by 19
LncRNA SOX1‐OT V1 acts as a decoy of HDAC10 to promote SOX1‐dependent hESC neuronal differentiation
Xi, J., Xu, Y., Guo, Z., Li, J., Wu, Y., Sun, Q., Wang, Y., Chen, M., Zhu, S., Bian, S., et al. (2021) · EMBO Reports · doi:10.15252/embr.202153015 · Cited by 20
Chromatin Acetylation Status in the Manifestation of Neurodegenerative Diseases
Boutillier, A., Rouaux, C., Panteleeva, I., & Loeffler, J. (2007) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/1-4020-5466-1_12 · Cited by 19
Torres, O. V. (2022) · Genes · doi:10.3390/genes13050892 · Cited by 20
Kim, J. Y., & Casaccia, P. (2010) · Cell Cycle · doi:10.4161/cc.9.18.12716 · Cited by 17
Zinc-Dependent Histone Deacetylases in Lung Endothelial Pathobiology
Patil, R. S., Maloney, M. E., Lucas, R., Fulton, D. J., Patel, V. S., Bagi, Z. A., Kovács‐Kása, A., Kovács, L., Su, Y., & Verin, A. D. (2024) · Biomolecules · doi:10.3390/biom14020140 · Cited by 15
Growth attenuation is associated with histone deacetylase 10-induced autophagy in the liver
Pinto, G., Shtaif, B., Phillip, M., & Gat‐Yablonski, G. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.08.031 · Cited by 16
Histone deacetylases and cardiovascular cell lineage commitment
Yang, J. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i5.852 · Cited by 15
Tsai, Y.-C., Rieß, O., Soehn, A. S., & Nguyen, H. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051999 · Cited by 14
Ling, H., Li, Y., Peng, C., Yang, S., & Seto, E. (2024) · NAR Cancer · doi:10.1093/narcan/zcae018 · Cited by 13
Bhattacharya, A., Amin, S. A., Kumar, P., Jha, T., & Gayen, S. (2023) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2023.108510 · Cited by 13
5 Histone Deacetylase Inhibitors: A Novel Class of Anti-Cancer Agents on its Way to the Market
Körner, M., & Tibes, U. (2008) · Progress in medicinal chemistry · doi:10.1016/s0079-6468(07)00005-7 · Cited by 13
Gray, S. G., Iglesias, A. H., Teh, B. T., & Dangond, F. (2003) · Gene Expression · doi:10.3727/000000003783992342 · Cited by 13
Histone deacetylase 10: A polyamine deacetylase from the crystal structure to the first inhibitors
Lambona, C., Zwergel, C., Fioravanti, R., Valente, S., & Mai, A. (2023) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2023.102668 · Cited by 11
Histone deacetylases in vascular permeability and remodeling associated with acute lung injury
Kovács, L., Kovács‐Kása, A., Verin, A. D., Fulton, D. J., Lucas, R., & Su, Y. (2018) · Vessel Plus · doi:10.20517/2574-1209.2018.06 · Cited by 10
Short communication: TNF-α and IGF-1 regulates epigenetic mechanisms of HDAC2 and HDAC10
Jiang, W., Block, M. E., & Boosani, C. S. (2022) · PLoS ONE · doi:10.1371/journal.pone.0263190 · Cited by 10
Characterization of the Role of Host Cellular Factor Histone Deacetylase 10 during HIV-1 Replication
Ran, X., Ao, Z., Olukitibi, T. A., & Yao, X. (2019) · Viruses · doi:10.3390/v12010028 · Cited by 10
Expression and Function of Histone Deacetylase 10 (HDAC10) in B Cell Malignancies
Powers, J. J., Lienlaf, M., Perez-Villarroel, P., Deng, S., Knox, T. J., Villagra, A., & Sahakian, E. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3667-0_10 · Cited by 10
Chicken HDAC2 down-regulates IgM light chain gene promoter activity
Takechi, S., Adachi, M., & Nakayama, T. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02630-x · Cited by 9
Zhou, Y., Luo, Q., Gu, L., Tian, X., Zhao, Y., Zhang, Y., & Wang, F. (2025) · Pharmaceuticals · doi:10.3390/ph18040563 · Cited by 9
Small Molecular Immune Modulators as Anticancer Agents
Han, Y., Zhu, L., Wu, W., Zhang, H., Hu, W., Dai, L., & Yang, Y. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-3266-5_22 · Cited by 8
Zheng, J., Li, Y., Liu, N., Zhang, J., Liu, S., & Tan, H. (2022) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2022.09.002 · Cited by 7
Histone Deacetylase Inhibitors in APL and Beyond
Petrie, K. R., Prodromou, N. V., & Zelent, A. (2007) · Springer eBooks · doi:10.1007/978-3-540-34594-7_10 · Cited by 7
Pharmacoepigenetics of Histone Deacetylase Inhibitors in Cancer
Garmpis, N., Damaskos, C., Garmpi, A., Valsami, S. I., & Dimitroulis, D. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813939-4.00013-9 · Cited by 5
Molecular Structure and Function of Zinc-Dependent Histone Deacetylases
Christianson, D. W. (2026) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-051424-053005 · Cited by 4
HDAC7 promotes ovarian cancer malignancy via AKT / mTOR signalling pathway
Feng, Q., Sheng, H., Liu, X., Yan, Z., Sheng, K., Li, Y., Zhang, P., & Sheng, X. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70120 · Cited by 4
Qiu, F., Huang, Y., Dzięgielewska, K. M., Habgood, M. D., & Saunders, N. R. (2025) · European Journal of Neuroscience · doi:10.1111/ejn.70139 · Cited by 5
Cai, S., Weng, J., Zhang, I. Y., & Zhu, Y. (2025) · JACS Au · doi:10.1021/jacsau.5c00842 · Cited by 3
Кукушкин, А. Н., Svetlikova, S. B., Aksenov, N., & Поспелов, В. А. (2023) · Cell and Tissue Biology · doi:10.1134/s1990519x23020098 · Cited by 3
Zheng, B., Jiang, X. F., Liu, Y., Cheng, F., Zhang, Y., Niu, C., Cong, Z., Niu, Z., & He, W. (2024) · Discover Oncology · doi:10.1007/s12672-024-01018-9 · Cited by 4
Metadata
- Authors
- Guardiola, A. R., & Yao, T.-P.
- Affiliations
- Duke Medical Center (US)
- Corresponding author
- Yao, Tso-Pang
- ORCID
- Yao, Tso-Pang
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-02
- Volume
- 277
- Issue
- 5
- Pages
- 3350-3356
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1987366741
- Cited by
- 253
- References
- 30
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 7 · 2023: 10 · 2022: 10 · 2021: 16 · 2020: 10 · 2019: 5 · 2018: 9 · 2017: 9 · 2016: 3 · 2015: 11 · 2014: 11 · 2013: 8 · 2012: 13
- FWCI
- 5.56
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Damon Runyon Cancer Research Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Keywords
- HDAC10, histone deacetylase, class II HDACs, HDAC6, transcriptional repression, nuclear localization, cytoplasmic localization, histone acetylation, deacetylase inhibitors
- MeSH terms
- Histone Deacetylase 6, Amino Acid Sequence, Cell Line, Chromosome Mapping, Chromosomes, Human, Pair 22, Cloning, Molecular, Gene Expression Regulation, Histone Deacetylases, Humans, Molecular Sequence Data, Phylogeny, Recombinant Proteins, Repressor Proteins, Transcription, Genetic, Transfection, Polymerase Chain Reaction, Sequence Alignment, Sequence Homology, Amino Acid, DNA Primers, Catalytic Domain
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review